Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study''
Br J Cancer
.
2018 Feb 6;118(3):e2.
doi: 10.1038/bjc.2017.406.
Epub 2017 Nov 16.
Authors
Luca Triggiani
1
,
Rosario Mazzola
2
,
Stefano Maria Magrini
1
,
Filippo Alongi
2
3
,
Michela Buglione
1
Affiliations
1
Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
2
Radiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy.
3
University of Brescia, Brescia, Italy.
PMID:
29149106
PMCID:
PMC5808026
DOI:
10.1038/bjc.2017.406
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Male
Neoplasm Recurrence, Local / radiotherapy
Prostatic Neoplasms / radiotherapy*
Radiosurgery*